Edition:
United States

Protagonist Therapeutics Inc (PTGX.OQ)

PTGX.OQ on NASDAQ Stock Exchange Global Market

9.06USD
20 Aug 2018
Change (% chg)

-- (--)
Prev Close
$9.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
76,180
52-wk High
$23.68
52-wk Low
$5.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 11.67 -0.408
Mar '18 10.78 -0.363
FY 2017 Dec '17 11.28 -0.151
Sep '17 8.78 -0.285
Jun '17 0.00 -0.888
Mar '17 0.00 -0.841
FY 2016 Dec '16 0.00 -0.767
Sep '16 0.00 -0.503
Jun '16 0.00 -0.500
Mar '16 0.00 -0.804
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 6.47 8.10 4.70 --
Quarter Ending Dec-18 3 15.21 27.80 7.82 --
Year Ending Dec-18 4 39.20 54.90 30.00 16.70
Year Ending Dec-19 4 25.58 43.80 12.50 62.33
Earnings (per share)
Quarter Ending Sep-18 4 -0.43 -0.12 -0.69 --
Quarter Ending Dec-18 4 -0.17 0.14 -0.47 --
Year Ending Dec-18 4 -1.30 -0.71 -1.89 -2.42
Year Ending Dec-19 4 -1.73 -0.98 -2.20 -3.27
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 99.36 30.45
P/E High - Last 5 Yrs. -- 272.05 47.36
P/E Low - Last 5 Yrs. -- 95.21 24.74
Beta -- 0.78 0.84
Price to Sales (TTM) 4.99 126.22 5.98
Price to Book (MRQ) 1.79 13.00 3.69
Price to Tangible Book (MRQ) 1.97 22.28 5.63
Price to Cash Flow (TTM) -- 64.21 20.97
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.37 1.78
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.47 -5.93
Payout Ratio(TTM) -- 6.14 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 158.89 7.18
Sales (TTM) vs TTM 1 Yr. Ago -- 91.20 12.05
Sales - 5 Yr. Growth Rate -- 24.34 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 53.98 74.27 23.85
EPS (TTM) vs TTM 1 Yr. Ago 59.74 -- --
EPS - 5 Yr. Growth Rate -- 23.23 7.52
Capital Spending - 5 Yr. Growth Rate -- 36.95 8.06

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.50
Current Ratio (MRQ) 4.69 5.42 3.53
LT Debt to Equity (MRQ) 0.00 19.75 11.27
Total Debt to Equity (MRQ) 0.00 23.48 14.23
Interest Coverage (TTM) -- -186.89 31.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.13 55.23
Gross Margin - 5 Yr. Avg. -- 52.64 53.33
EBITD Margin (TTM) -59.95 -- --
EBITD - 5 Yr. Avg -- -189.34 15.82
Operating Margin (TTM) -61.06 -673.76 3.86
Operating Margin - 5 Yr. Avg. -- -202.74 10.95
Pre-Tax Margin (TTM) -56.92 -665.74 4.16
Pre-Tax Margin - 5 Yr. Avg. -- -203.67 11.12
Net Profit Margin (TTM) -56.92 -655.99 0.98
Net Profit Margin - 5 Yr. Avg. -- -201.27 7.47
Effective Tax Rate (TTM) -- 12.18 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 773,055 5,071,848 718,909,906
Net Income/Employee (TTM) -440,018 -6,208,777 83,624,743
Receivable Turnover (TTM) 7.83 6.39 5.38
Inventory Turnover (TTM) -- 2.25 3.51
Asset Turnover (TTM) 0.41 0.42 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -23.28 1.88 10.04
Return on Assets - 5 Yr. Avg. -- 2.31 10.94
Return on Investment (TTM) -28.54 2.89 12.63
Return on Investment - 5 Yr. Avg. -- 1.68 14.14
Return on Equity (TTM) -28.69 1.65 14.82
Return on Equity - 5 Yr. Avg. -- -6.94 15.50
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 18.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Protagonist Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 94.84%
# of Holders: 94
Total Shares Held: 22,680,242
3 Mo. Net Change: 2,609,584
# New Positions: 20
# Closed Positions: 31
# Increased Positions: 49
# Reduced Positions: 57
# Net Buyers: -8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.